This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.
Globally, lung cancer is the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for… More »
Meeting News Coverage Video
August 20, 2015
CHICAGO — The PALOMA-3 trial, which evaluated the addition of palbociclib to fulvestrant, demonstrated… More »
This activity is supported by an educational grant from Merck & Co., Inc.
The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval… More »